Roberto Filippi

Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild‐type <scp><i>KRAS</i></scp> advanced biliary tract cancer: A randomized phase 2 trial (<scp>V</scp>ecti‐<scp>BIL</scp> study)

Francesco Leone, Donatella Marino, Stefano Cereda et al. · Cancer · 2015 · 138 citations · Full text

Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes

Fotios Loupakis, Ilaria Depetris, Paola Biason et al. · The Oncologist · 2020 · 107 citations · Full text

Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer

Lorenzo Fornaro, Stefano Cereda, Giuseppe Aprile et al. · British Journal of Cancer · 2014 · 77 citations · Full text

The prognostic nutritional index predicts survival and response to first‐line chemotherapy in advanced biliary cancer

Massimiliano Salati, Roberto Filippi, Caterina Vivaldi et al. · Liver International · 2019 · 57 citations · Full text

CT perfusion in solid-body tumours. Part I: technical issues

Giuseppe Petralia, Lorenzo Preda, Gabriele D’Andrea et al. · La radiologia medica · 2010 · 46 citations

Oncologic Imaging, Medical Imaging, Ct Perfusion +4